Interferon-Alpha 2-a and Its Dual Effect in Trea... - MPN Voice

MPN Voice

10,445 members14,398 posts

Interferon-Alpha 2-a and Its Dual Effect in Treating Two Diseases (Hepatitis C and Polycythemia Vera)

Manouche profile image
4 Replies

 »Here, we report a 56-years-old male patient with hepatitis C virus infection and PV, who was treated with IFN for his chronic hepatitis C, which resulted in significant improvement of HB as well as normalization of his bone marrow and eradication of the clone (Jak2V617F).

…The patient received pegylated IFNα 2a in a dose of 180 mcg/week for 5 years. It took 2 years for the complete eradication of hepatitis C. He was cured of hepatitis c virus, and hemoglobin levels were normal (14–15.5 gm/dL), and repeated Jak2 v617f was negative. Bone marrow biopsy was done to evaluate for PV at the bone marrow level (panmyelosis). The bone marrow reported normal (no features suggestive of PV or other MPNs) »

karger.com/Article/FullText...

Written by
Manouche profile image
Manouche
To view profiles and participate in discussions please or .
Read more about...
4 Replies
hunter5582 profile image
hunter5582

Very interesting and hopeful outcome. A rare case of two birds with one stone.

Joetcalr profile image
Joetcalr

interesting. I had hepatitis A 40 years before ET diagnosis. I’m wondering if it’s more common prior to getting an MPN, than in general population?

Bluetop profile image
Bluetop

Oh that's a positive outcome!

MAP44 profile image
MAP44

Thank you! Interesting read 🍻

You may also like...

Interferon-Alpha Reduces Myelofibrosis Risk, Mortality Rate in Low- and High-Risk Polycythemia Vera

of high-risk patients was similarly higher in patients treated with IFN, with a 20-year probability...

Effective Management of Polycythemia Vera With Ropeginterferon Alfa-2b Treatment

high level of JAK2V617F allelic burden reduction. The results suggested that treatment of patients...

Cost–effectiveness of ropeginterferon alfa-2b-njft for the treatment of polycythemia vera

model showed that patients who received ropeginterferon alfa-2b-njft had more years alive (0.4),...

interferon alpha effectiveness for ET

Moving towards disease modification in polycythemia vera

treatment landscape of PV and outline our vision for a patient-centered, phlebotomy-free, treatment...